Latanoprostene bunod 0.024% significantly reduced IOP across patient groups and appeared well regarded among physicians and ...

An urgent recall has been issued for a common inhaler used by people with severe asthma. The UK medicines regulator, the MHRA, have said that the Flutiform 250 micrograms inhaler is to be returned to ...